deamino-arginine-vasopressin and Blue-Toe-Syndrome

deamino-arginine-vasopressin has been researched along with Blue-Toe-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for deamino-arginine-vasopressin and Blue-Toe-Syndrome

ArticleYear
Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
    Acta haematologica, 2003, Volume: 109, Issue:4

    Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Autoantibodies; Autoimmune Diseases; B-Lymphocyte Subsets; Blue Toe Syndrome; Bradycardia; Combined Modality Therapy; Compartment Syndromes; Deamino Arginine Vasopressin; Factor VII; Factor VIIa; Factor VIII; Female; Hematoma; Hemorrhage; Humans; Immunoglobulins, Intravenous; Pacemaker, Artificial; Plasmapheresis; Platelet Transfusion; Postoperative Hemorrhage; Recombinant Proteins; Rituximab

2003